Filing metadata

Accession number
0001606074-19-000009
Form type
Form 4
Filer
NGM BIOPHARMACEUTICALS INC
CIK
CIK 1426332
Filed
May 22, 2019
Reporting period
May 20, 2019
Description
Insider transaction

Explore SEC Filings Hub